Who has invested in AGTC?

Forbion, Syncona, Oxford Science Enterprises, TCGX, Advent Life Sciences are named among the investors backing AGTC.

AGTC Funding: $290M Raised, Series B (2024)

AGTC funding overview

AGTC is based in Alachua, Florida. AGTC has raised $290M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in July 2024. The round record for AGTC runs through 2024; nothing later has been disclosed. Investors on record include Forbion, Syncona, Oxford Science Enterprises, TCGX, Advent Life Sciences. 5 distinct backers are named across the disclosed rounds.

AGTC at a glance

Total raised: $290M
Latest round: Series B
Latest round date: July 2024
Headquarters: Alachua, Florida
Notable investors: Forbion, Syncona, Oxford Science Enterprises, TCGX, Advent Life Sciences

Frequently asked about AGTC funding

How much has AGTC raised?: AGTC has raised $290M in total disclosed funding across the rounds on record.
Who has invested in AGTC?: Forbion, Syncona, Oxford Science Enterprises, TCGX, Advent Life Sciences are named among the investors backing AGTC.
What was the latest AGTC funding round?: The most recent disclosed round is a Series B, announced in July 2024.
Where is AGTC based?: AGTC is based in Alachua, Florida.
When did AGTC last raise?: The last disclosed AGTC round closed in July 2024 at Series B.

Round data for AGTC is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Alachua and backer lists below.

AGTC Funding: $290M Raised, Series B (2024)

AGTC funding overview

AGTC at a glance

Frequently asked about AGTC funding

Companies related to AGTC (18)

Browse related funding lists (8)